CMS revises competitive bidding program for durable medical equipment, affecting supply contracts and patient access concerns within Medicare's medical device market.

New Medicare drug price negotiations reduce government costs on 15 high-spend medications, including cancer and diabetes treatments, saving $12 billion annually.

CMS's Medicare Advantage proposal reintroduces the reward factor, affecting insurer payments by $13B, and phases out the inpatient-only list, impacting outpatient care and rural health strategies.

Starting in 2026, Washington state will implement an AI-driven prior authorization pilot for traditional Medicare, raising new compliance and access challenges. Learn about the pilot's impact on Medicare claims processing and healthcare providers.

Montana residents face health insurance premium increases up to 231% as enhanced ACA tax credits expire, impacting affordability and coverage decisions.

UnitedHealthcare will stop requiring prior authorizations for certain nuclear imaging, obstetrical ultrasound, and echocardiogram procedures starting in 2026, across multiple plan types including Medicare Advantage and commercial plans.

Explore effective health insurance strategies for women managing chronic illnesses during open enrollment, focusing on plan tiers, cost management, and provider networks.

Overview of U.S. stock market rally, Federal Reserve Chair nomination prospects, and Tennessee special election's impact on healthcare and insurance markets in December 2025.

Enhanced premium tax credits supporting health insurance affordability for Utah small-business owners face expiration, risking access to care for cancer patients and others.

The Trump administration finalizes agreements reducing Medicare prices for 15 drugs, aiming to save billions and impact Medicare Part D plans and drug affordability policies.